<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to assess cardiac tolerance of halofantrine in children, we studied, retrospectively, 15 non complicated <z:e sem="disease" ids="C0024535" disease_type="Disease or Syndrome" abbrv="">falciparum malaria</z:e> cases treated with halofantrine, and focused on the effect on ventricular repolarisation </plain></SENT>
<SENT sid="1" pm="."><plain>Our data showed that halofantrine can produce a moderate QTc prolongation without any life-threatening <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>As long as contraindications of the drug are respected, this treatment should be considered as a therapeutical option in young children presenting with non complicated <z:e sem="disease" ids="C0024535" disease_type="Disease or Syndrome" abbrv="">falciparum malaria</z:e> </plain></SENT>
</text></document>